Trial intelligence / Profile preview

EVICEL as an adjunct to gastrointestinal anastomosis techniques

KCT0000490Phase 3Not yet recruiting

Sponsor
Johnson & Johnson
Start
Aug 2012
Modality
Recombinant Proteins and Enzymes, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

A Phase 3 trial of porcine fibrin sealant in colorectal cancer (CRC), rectal cancer, Colorectal disease, sponsored by Johnson & Johnson. Planned start Aug 2012; status: not yet recruiting.

02

Drugs

porcine fibrin sealant
03

Conditions

colorectal cancer (CRC)rectal cancerColorectal disease

Beyond the preview

Go deeper on KCT0000490.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0000490.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call